Company Overview and News

 
Ghosn molding a Nissan-Renault that can cruise on auto-pilot

2018-04-18 themalaymailonline
Carlos Ghosn, Chairman and CEO of the Renault-Nissan Alliance, gestures as he attends a news conference to unveil Renault next mid-term strategic plan in Paris October 6, 2017. — Reuters picTOKYO, April 18 — Carlos Ghosn said he’s seeking to change the alliance between Nissan Motor Co and Renault SA so it will function independently of leadership once he is no longer chairman.
Upvote Downvote

 
Ghosn mulling changes to Nissan-Renault structure

2018-04-17 japantimes.co.jp
Nissan Motor Co. confirmed Tuesday that Carlos Ghosn, chairman and CEO of the Renault-Nissan Alliance, is thinking about reviewing the cross-shareholding arrangement between the Japanese and French automakers.
Upvote Downvote

 
Ghosn Is Considering Changes to Nissan-Renault Structure, Nikkei Says - Bloomberg

2018-04-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
General Motors to Cut Jobs in Ohio Plant as Car Demand Wanes

2018-04-16 zacks
General Motors Company (GM - Free Report) announced that it is laying off around 1,500 workers at its plant in Lordstown, OH, per CNBC. The auto giant took such a decision due to the dramatically slowing demand for compact cars. Notably, the plant manufactures only the Chevy Cruze model and it employs around 3,000 workers. In fact, the demand for sedans declined steeply in recent times. This year, car sales declined 13.
Upvote Downvote

 
Renault plans to make India a hub for electric vehicle components

2018-04-15 livemint
New Delhi: Renault SA has placed orders for manufacturing electric motors and transmission parts for its electric vehicles with one Indian automotive component manufacturer and have plans to make India a manufacturing hub for electric vehicle (EV) components in the long term. The local unit of the French car maker is also working on developing EVs for the global market in Chennai, two people aware of the developments said.
Upvote Downvote

 
Mercedes plans electric S-Class to challenge Tesla’s flagship

2018-04-12 livemint
Frankfurt: Mercedes-Benz is developing a battery-powered sedan about the size of its $90,000 flagship S-Class, challenging Tesla Inc.’s Model S for high-end electric-car buyers.
Upvote Downvote

 
Mercedes-Benz Plans Electric Sibling of Flagship S-Class Sedan - Bloomberg

2018-04-11 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Ep. 59: Exposing The Supply Chain Security Nightmare

2018-04-11 seekingalpha
When most people think of the words "supply chain," they harken back to the classroom definition - the sequence of steps and processes involved in the production and distribution of a commodity or product in a factory. While that's true, over the past several decades, the move toward low-cost outsourcing has dramatically changed, where companies source their components and finished products as well as the multitude of players that supply them.
Upvote Downvote

 
Bloomberg’s Week in Pictures - Bloomberg

2018-04-07 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
EV Company News For The Month Of March 2018

2018-04-02 seekingalpha
EV market news - Norway embraces electric ferries. Electric planes to race from London to Darwin in 2019.
Upvote Downvote

 
Is RENAULT (RNLSY) a Great Stock for Value Investors?

2018-04-02 zacks
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?
Upvote Downvote

 
Nissan, Renault said in merger talks as alliance deepens

2018-03-30 themalaymailonline
Carlos Ghosn, Chairman and CEO of the Renault-Nissan Alliance, attends a news conference to unveil Renault's mid-term strategic plan in Paris, France, October 6, 2017. — Reuters picTOKYO, March 30 — Renault SA and Nissan Motor Co are in talks to merge, seeking to solidify their two-decade-old alliance under a single stock as an unprecedented shift toward electric and shared cars transforms the industry, people with knowledge of the matter said.
Upvote Downvote

 
Carlos Ghosn Wants a Full-Fledged Renault-Nissan Union - Bloomberg

2018-03-29 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Stocks Rebound After Volatile Week as Dollar Slips: Markets Wrap - Bloomberg

2018-03-29 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Nissan, Renault in talks to merge, create a new company

2018-03-29 livemint
Southfield/New York: Renault SA and Nissan Motor Co. are in talks to merge and create a new automaker that trades as a single stock, people with knowledge of the matter said.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...